This Article  • Full text  • PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Contact me when this article is cited  Related Content  • Similar articles in JAMA  Topic Collections  • Pulmonary Diseases, Other  • Genetics, Other  • Oncology  • Lung Cancer  • Ovarian Cancer  • Alert me on articles by topic

Tracy Hampton, PhD

JAMA. 2006;296:1958.

	Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

The National Cancer Institute and the National Human Genome Research Institute announced that they will begin sequencing the genes of 3 cancers—lung, brain (glioblastoma), and ovarian cancer—in the pilot phase of The Cancer Genome Atlas (TCGA) project (http://cancergenome.nih.gov). TCGA, launched last December, is a collaborative 3-year pilot project to test the feasibility of using large-scale genomic analysis technologies to determine the important genetic changes involved in cancer.

Lung, brain, and ovarian cancers were selected first because of availability of specimens that met TCGA's scientific, technical, and ethical requirements. The Lung Cancer Tissue Bank of the Cancer and Leukemia Group B clinical trials group, which is housed at the Brigham and Women's Hospital, in Boston, the M.D. Anderson Cancer Center, in Houston, and the Gynecologic Oncology Group tissue bank at the Children's Hospital of Ohio State University, in Columbus, will provide the specimens.

TCGA will ultimately . . . [Full Text of this Article]